In fact, the co-presence of elevated pulmonary PGE2 and TRPV1 stimulants has been believed to responsible for coughs in patients with asthma, idiopathic pulmonary fibrosis, idiopathic chronic cough and COPD ([27] and for review, see [28]). Here, TRPV1 is linked to chronic obstructive pulmonary disease.